Sutro Biopharma, Inc. STRO
8.72 USD +0.22 (+2.59%)
Regular-session close
8.72 0.00 0.00%
After hours · Nov 19, 4:26 PM ET
8.48 Day range 8.98
7.15 52-week range 43.85
- YTD
- -24.63%
- 1 year
- -4.18%
STRO revenue history
Revenue is income from the company’s ordinary business activities.
102,484,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 102,484,000 | 40,441,000 | 65.18% |
| FY 2024 | 2024-12-31 | 62,043,000 | -91,688,000 | -59.64% |
| FY 2023 | 2023-12-31 | 153,731,000 | 85,959,000 | 126.84% |
| FY 2022 | 2022-12-31 | 67,772,000 | 5,892,000 | 9.52% |
| FY 2021 | 2021-12-31 | 61,880,000 | 19,158,000 | 44.84% |
| FY 2020 | 2020-12-31 | 42,722,000 | -14,000 | -0.03% |
| FY 2019 | 2019-12-31 | 42,736,000 | 4,317,000 | 11.24% |
| FY 2018 | 2018-12-31 | 38,419,000 | -13,322,000 | -25.75% |
| FY 2017 | 2017-12-31 | 51,741,000 | -7,990,000 | -13.38% |
| FY 2016 | 2016-12-31 | 59,731,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:16.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
